Table 3.
Treatments and outcomes of patients with AICN
| Patient no. | AMX arrest | Volume expansion | Solutes | Double J catheterization | AMX rechallenge | Delay of reintroduction, days | RRT | Return of baseline sCr before discharge | Delay between recovery and AMX arrest, days | sCr on discharge, mg/dl | Length of follow-up, days | Last sCr, mg/dl | Last eGFR, ml/min/1.73 m2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | 1 | 0 | 0 | 0 | 0 | 1 | 8 | 0.73 | 184 | 0.9 | 66 | ||
| 2 | 1 | 1 | Crystalloids | 1 | 0 | 0 | 0 | 23 | 1.46 | 287 | 0.6 | 103 | |
| 3 | 1 | 1 | Crystalloids/oral sodium bicarbonate intake | 0 | 1 | 7 | 0 | 1 | 3 | 0.86 | 0 | 0.86 | 67 |
| 4 | 1 | 1 | Oral sodium bicarbonate intake | 0 | 1 | 7 | 0 | 1 | 1 | NA | 3 | 1.1 | 51 |
| 5 | 1 | 1 | Crystalloids | 0 | 1 | 0 | 1 | 0 | 3.4 | 68 | 0.86 | 92 | |
| 6 | 1 | NA | NA | 0 | 0 | 0 | 1 | 5 | NA | 128 | 0.48 | 136 | |
| 7 | 1 | NA | NA | 1 | 0 | 0 | 1 | 8 | NA | 602 | 0.58 | 119 | |
| 8 | 1 | 1 | Crystalloids/HCO3 Na 1.4% | 0 | 0 | 0 | 1 | 14 | 2.14 | 305 | 0.71 | 83 | |
| 9 | 1 | 1 | Ringer lactate | 0 | 1 | 19 | 0 | 1 | 18 | 0.97 | 171 | 0.62 | 130 |
| 10 | 1 | 1 | Crystalloids/HCO3 Na 1.4% | 0 | 0 | 0 | 1 | 2 | 0.53 | 0 | 0.53 | 130 |
AICN, amoxicillin-induced crystal nephropathy; AMX, amoxicillin; sCr, serum creatinine; eGFR, estimated glomerular filtration rate by modification of diet in renal disease equation; NA, not available; RRT, renal replacement therapy.